Navigation Links
Advanced Life Sciences Announces First Quarter 2008 Financial Results
Date:5/7/2008

CHICAGO, May 7 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer and respiratory diseases, today announced its financial results for the first quarter ended March 31, 2008. The net loss available to common shareholders for the three months ended March 31, 2008 was $3.6 million or ($0.09) per share compared to $10.5 million or ($0.37) per share for the three months ended March 31, 2007. The decrease in the net loss reflects lower development expenses related to the cethromycin pivotal Phase III clinical program, which was completed in November 2007.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080218/ALSLOGO)

"Having confirmed the regulatory plans for cethromycin, we are pushing forward aggressively to achieve our partnering and NDA submission goals," said Michael T. Flavin, Ph.D., chairman and chief executive officer of Advanced Life Sciences. "We believe cethromycin can be an important new drug in the treatment of community acquired pneumonia and, if approved, can assist in the emerging battle against drug resistant bacteria."

The company ended the first quarter of 2008 with cash and cash equivalents totaling $12.6 million. Cash used during the first quarter was approximately $5.7 million.

Operating Expense Analysis:

* Research and development expense. Total research and development

expense decreased $7.2 million to approximately $1.9 million for the

three months ended March 31, 2008 from approximately $9.1 million for

'/>"/>
SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Advanced Life Sciences to Host 2008 First Quarter Financial Results Conference Call and Webcast
2. Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
3. Avastin Used in Combination with Drugs from Bristol-Myers Squibb Has Advantages in Survival Rates Over the Current Sales-Leading Therapy for Advanced Ovarian Cancer
4. Advanced Life Sciences Regains Compliance With Nasdaq Listing Requirements
5. Advanced Life Sciences Announces Plan to Submit NDA for Cethromycin
6. Encision Launches Next Generation of EnTouch(R) Handles for Advanced Laparoscopic Procedures
7. Advanced Life Sciences Receives Nasdaq Notification
8. Advanced Life Sciences Announces Fourth Quarter and Full Year 2007 Financial Results
9. Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer
10. Advanced Life Sciences To Host 2008 Fourth Quarter and Full-Year Financial Results Conference Call and Webcast
11. Advanced Medical Specialties Joins US Oncology Network
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)JERUSALEM, Israel, December 2 Gamida Cell announced today,a feasibility study evaluating the preclinical (animal study) safety and,efficacy of a gene therapy product which combines technology from We
(Date:12/2/2009)RESTON, Va., Dec. 2 /PRNewswire-Asia-FirstCall/ -- Emerald Dairy, Inc.,("Emerald Dairy" or the "Company") (OTC Bulletin Board: EMDY), a leading,producer and distributor of infant and children,s formul
(Date:12/2/2009)QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today annou
(Date:12/2/2009)The Scientist, a leading scientific magazine covering the life sciences, ranked Photometrics’ Evolve “Intelligent” EMCCD camera fourth among the publication’s “Top 10 Inn
Breaking Biology Technology:Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3
... recently announced the opening of a new radio fre...mpany,s global headquarters in Milwaukee. The lab,...to help manufacturers facing production and invent...n make RFID technology an integral part of their d...ly change supply chain management and the way indu...
...ow blood flows through stents after opening clogge...edical College of Wisconsin Cardiovascular Center ... thinner and fewer linkages may be the basis of a ...shed in the July 2004 issue of the Journal of App...s for treating heart blockages is balloon angiopla...
... and beyond have been given a new Web-based tool t...s and interns among the graduates and students of ...b site brings together the career services office...ides links to the career services resources of the...sconsin Technical College System and many of the p...
Other Biology Technology:Rockwell Automation opens new RFID lab 2Medical College discovery leads to new stents 2New Web site makes recruiting from Wisconsin universities easier 2
(Date:12/3/2009)Coral reef fish can undergo a personality change in warmer water, according to an intriguing new study suggesting that climate change may make some species more aggressive. , Experiments with two spe
(Date:12/3/2009)Spanish researchers have measured CO2 levels for the past three years in the troposphere (lower atmosphere) over a sparsely inhabited rural area near Valladolid. The results, which are the first of th
(Date:12/3/2009)The 30-year record low in Antarctic snowmelt that occurred during the 2008-09 austral summer was likely due to concurrent strong positive phases for two main climate drivers, ENSO (El Nio - Southern O
Breaking Biology News(10 mins):Fish with attitude: Some like it hot 2CO2 levels rising in troposphere over rural areas 2CCNY professor foresees rising Antarctic snowmelt 2The Scientist Magazine Recognizes febits HybSelect 28TM 29 Among the Winners of Top 10 Innovations of 2009 6684 1The Scientist Magazine Recognizes febits HybSelect 28TM 29 Among the Winners of Top 10 Innovations of 2009 6684 2Smokers Inhaling Germs With Each Cigarette 62450 1Smokers Inhaling Germs With Each Cigarette 62450 2Smell of old books offers clues to help preserve them 62445 1
... Covering ship hulls with artificial shark skin co...ine organisms such as barnacles on ship hulls is a...l industry. Shark skin offers a structural design ...h Liedert from the University of Applied Sciences,...plication of artificial shark skin in a new anti-f...
... Scientists have uncovered new information about a...ignant human tumor cells. The findings, published ...vance knowledge about epidermal growth factor rece... receptor that stimulates cell growth by transmitt... EGFR is often present at abnormally elevated leve...
... A common chemical used in the manufacturing and p...iac muscle cell membranes and prevent heart failur...chenne muscular dystrophy, according to scientists...he mutation in the dystrophin gene causes the prog...people with MD. But the mutation affects cardiac m...
Other Biology News:Physical and functional interaction of key cell growth molecules linked to cancer 2Chemical 'band-aid' prevents heart failure in mice with muscular dystrophy 2Chemical 'band-aid' prevents heart failure in mice with muscular dystrophy 3Chemical 'band-aid' prevents heart failure in mice with muscular dystrophy 4
...t and reliable scalable automation for today's dru...ment laboratories. Staccato systems are available ...ies, Application Series and Custom Systems Series....volutionary new base table design called iBLOX&tra...
...t and reliable scalable automation for today's dru...pment laboratories. Staccato systems are available...ries, Application Series and Custom Systems Series...Series systems use a revolutionary new base table ...
Corning Spin-X Centrifuge Tube Filters from Sigma-Aldrich
HybriWell Sealing System from Grace Bio Labs
Biology Products: